Skip to main content

Table 1 Viral proteins and their role in evading NK cell's response

From: Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we?

Virus

Protein

Mechanism

B19

?

Counteracts NK cell differentiation, activation, and cytotoxicity by decreasing the expression of TNF-α mRNA [86]

BK

?

Decreases KIR3DS1 activating receptor [87]

HPV

E6 and E7

Decrease the production of IFNs [88,89,90]

Inhibits inflammasome-induced inflammation [90, 91]

?

Downregulates the activating receptors NKp30, NKp46, and NKG2D [92]

?

Weakens the cytotoxic capacity of NK cells [93]

HCMV

UL16

Avoids being detected by NK cells by binding to ULBP1 and MICB [94]

UL18

binds to an MHC-I inhibitory receptor LIR-1 [95]

UL40

upregulates the expression of the HLA-E [96]

UL141

Downregulates the surface CD112 and CD155 [97, 98]

Downregulates surface TRAIL death receptors [99]

UL142

downregulates the cell surface amount of MICA by retention in the cis-Golgi apparatus [100]

UL148A

Downregulates the MICA by lysosomal degradation [101]

US18 and US20

Lysosomal degradation of MICA and B7-H6 [102, 103]

US9

Downregulates MICA*008 by proteasomal degradation [104]

US12

Targets different NK cell ligands, adhesion molecules, and cytokine receptors [105]

pp65

Weakens the cytotoxic capacity of NK cells by disrupting the CD3ζ signaling pathway [79]

gp34, gp95, gpRL13, and gp68

Avoids ADCC by acting as CD16 (FcγIII receptor) analogs [105]

HSV and VZV

?

Decreases MICA, ULBP1, ULBP2, and ULBP3 [105]

gD

Avoids being detected by NK cells by decreasing CD112 [106]

gE-gI complex

Avoids ADCC by acting as CD16 (FcγIII receptor) analogs [105]

HHV-7

U21

Downregulates the surface levels of MICA and MICB [107]

Reduces the ULBP1 protein by lysosomal degradation [107]

KSHV

ORF54-encoded protein

downregulates an unknown ligand of NKp44 [108]

vMIP-II (vCCL2)

acts as an antagonist for Fractalkine and RANTES chemokine receptors to inhibit NK cell migration [109]

K5

Downregulates MICA and AICL cell surface levels by intracellular retention [110]

SARS-CoV-2

Spike

Increases the surface expression of HLA [111]

DENV

?

Avoids being detected by NK cells by upregulating MHC-I [112]

HCV

?

downregulates the expression of NKG2D and NKp30 [113]

RSV

?

downregulates the expression of NKG2D and NKp44 [114]

EBOV

VP24 and VP35

Act as antagonists to IFNs [115, 116]

Marburg virus

VP40

Blocks the type I IFNs signaling [117]

HIV

nef

Decreases the cell surface amount of MICA, ULBP1, and ULBP2 [77]

Decreases the NK cell activity by intracellular retention of NKp44 ligands [118]

nef and vpn

downregulates the expression of NTB-A and CD155 [119,120,121]

?

Impairs the expression and function of NKG2D [122]